Pauline Shambrook, Adèle Hesters, Clémence Marois, Daniel Zemba, Jérôme Servan, Bertrand Gaymard, Fernando Pico, Cécile Delorme, Catherine Lubetzki, Isabelle Arnulf, Dimitri Psimaras, Jérôme Honnorat, Ana Gales, Aurélie Méneret
{"title":"Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease.","authors":"Pauline Shambrook, Adèle Hesters, Clémence Marois, Daniel Zemba, Jérôme Servan, Bertrand Gaymard, Fernando Pico, Cécile Delorme, Catherine Lubetzki, Isabelle Arnulf, Dimitri Psimaras, Jérôme Honnorat, Ana Gales, Aurélie Méneret","doi":"10.1212/NXI.0000000000001009","DOIUrl":null,"url":null,"abstract":"Anti-IgLON5 disease is a rare disorder characterized by the variable association of movement disorders, sleep disturbances, cognitive impairment, bulbar symptoms, and respiratory dysfunction. Pathophysiology likely involves both autoimmune and neurodegenerative processes, and prognosis is considered to be poor. Here, we report a case with a waxing and waning course, who eventually responded well to aggressive and sustained immunotherapy.","PeriodicalId":520720,"journal":{"name":"Neurology(R) neuroimmunology & neuroinflammation","volume":" ","pages":""},"PeriodicalIF":7.5000,"publicationDate":"2021-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c9/34/NEURIMMINFL2020037135.PMC8192057.pdf","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology(R) neuroimmunology & neuroinflammation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1212/NXI.0000000000001009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/7/1 0:00:00","PubModel":"Print","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8
Abstract
Anti-IgLON5 disease is a rare disorder characterized by the variable association of movement disorders, sleep disturbances, cognitive impairment, bulbar symptoms, and respiratory dysfunction. Pathophysiology likely involves both autoimmune and neurodegenerative processes, and prognosis is considered to be poor. Here, we report a case with a waxing and waning course, who eventually responded well to aggressive and sustained immunotherapy.